NCT04972331 (FOLAI) is a NA clinical trial of SMS Pre-notification in Shoulder Instability, sponsored by Institut de Chirurgie Reparatrice Locomoteur et Sports.

Who is sponsoring NCT04972331?

NCT04972331 is sponsored by Institut de Chirurgie Reparatrice Locomoteur et Sports.

What drugs are being tested in NCT04972331?

Interventions in NCT04972331: SMS Pre-notification, No Pre-notification.

What condition does NCT04972331 study?

NCT04972331 studies Shoulder Instability.

Is NCT04972331 still recruiting?

NCT04972331 is currently completed. Last updated 20 February 2026.

Last reviewed 2026-02-20 · How we verify

NCT04972331: FOLAI

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Automated AI Voice Calls for Postoperative Follow-up After Arthroscopic Shoulder Instability Surgery

Completed NA Last updated 20 February 2026

What this trial tests

NA trial testing SMS Pre-notification in Shoulder Instability in 310 participants. Completed in 13 February 2026.

Timeline

27 January 2026

Primary endpoint
6 February 2026

13 February 2026

Quick facts

Lead sponsor	Institut de Chirurgie Reparatrice Locomoteur et Sports
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	310
Start date	27 January 2026
Primary completion	6 February 2026
Estimated completion	13 February 2026
Sites	1 location across France

Drugs / interventions tested

SMS Pre-notification
No Pre-notification

Conditions studied

Shoulder Instability — all drugs for Shoulder Instability →

Sponsor

Institut de Chirurgie Reparatrice Locomoteur et Sports

Who can join

18 and older, any sex, with Shoulder Instability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective, single-center randomized clinical trial evaluates the technical efficacy, accuracy, and operational performance of an automated conversational artificial intelligence (AI) voice agent for postoperative follow-up after arthroscopic shoulder instability surgery. The study examines whether SMS pre-notification improves survey completion during the first automated outbound call and assesses the accuracy of AI-captured patient-reported outcomes compared with blinded human review.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Shoulder Instability

Currently open trials in the same condition.

NCT07457931 — Shoulder Instability Surgery: Latarjet Technique With Surgical Tape Versus Screw Fixation · NA · active not recruiting
NCT06963983 — Virtual Reality Rehabilitation for Shoulder Pathologies · NA · recruiting
NCT05564494 — Surgical Treatment of Recurrent Shoulder Dislocations · NA · recruiting
NCT07405827 — French Shoulder Instability Surgery Cohort Study · recruiting
NCT04520087 — Clinical and Radiographic Assessment After Surgical Treatment of Anterior Shoulder Dislocation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04972331 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut de Chirurgie Reparatrice Locomoteur et Sports
Last refreshed: 20 February 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04972331.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing